SUVEN LIFE SCIENCES
Quarterly Results Analysis [Dec2024]
SUVEN LIFE SCIENCES Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr |
Expenses | ₹41 Cr | ₹55 Cr | ₹32 Cr | ₹33 Cr | ₹49 Cr | ₹27 Cr | ₹32 Cr | ₹34 Cr |
Operating Income | ₹-39 Cr | ₹-52 Cr | ₹-31 Cr | ₹-30 Cr | ₹-46 Cr | ₹-24 Cr | ₹-28 Cr | ₹-32 Cr |
Other Income | ₹2 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹-39 Cr | ₹-50 Cr | ₹-28 Cr | ₹-28 Cr | ₹-42 Cr | ₹-13 Cr | ₹-24 Cr | ₹-28 Cr |
Profit After Tax | ₹-39 Cr | ₹-50 Cr | ₹-28 Cr | ₹-27 Cr | ₹-42 Cr | ₹-13 Cr | ₹-24 Cr | ₹-28 Cr |
EPS | ₹-1.79 | ₹-2.28 | ₹-1.29 | ₹-1.22 | ₹-1.92 | ₹-0.58 | ₹-1.10 | ₹-1.27 |
Industry Peers & Returns | 1W | 1M | 1Y |
SUVEN LIFE SCIENCES | 2.3% | 12.3% | 14.1% |
SUN PHARMACEUTICAL INDUSTRIES | -3.9% | 3% | 7.9% |
DIVIS LABORATORIES | -5% | -1.1% | 71.6% |
CIPLA | -4.4% | 0.2% | -1.7% |
TORRENT PHARMACEUTICALS | -1.6% | 6.5% | 26.2% |
DR REDDYS LABORATORIES | -2.4% | 2.4% | -5.4% |
MANKIND PHARMA | 2.4% | 7.1% | 3.9% |
ZYDUS LIFESCIENCES | -3.3% | -1% | -11.4% |
LUPIN | -5.4% | 3.4% | 26.8% |
SUVEN LIFE SCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -37.43 % |
Y-o-Y | -34.31 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹2 Cr | -37.43 | |
Sep2024 | ₹3 Cr | 155.77 | |
Jun2024 | ₹1 Cr | -57.82 | |
Mar2024 | ₹2 Cr | -2.69 | |
Dec2023 | ₹2 Cr | -19.90 | |
Sep2023 | ₹3 Cr | -19.41 | |
Jun2023 | ₹4 Cr | 45.42 | |
Mar2023 | ₹3 Cr | - |
SUVEN LIFE SCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹-39 Cr | Negative | |
Sep2024 | ₹-52 Cr | Negative | |
Jun2024 | ₹-31 Cr | Negative | |
Mar2024 | ₹-30 Cr | Negative | |
Dec2023 | ₹-46 Cr | Negative | |
Sep2023 | ₹-24 Cr | Negative | |
Jun2023 | ₹-28 Cr | Negative | |
Mar2023 | ₹-32 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | -2435.16% | Negative | |
Sep2024 | -2029.07% | Negative | |
Jun2024 | -3035.69% | Negative | |
Mar2024 | -1269.94% | Negative | |
Dec2023 | -1884.62% | Negative | |
Sep2023 | -768.3% | Negative | |
Jun2023 | -737.79% | Negative | |
Mar2023 | -1207.28% | - |
SUVEN LIFE SCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹-39 Cr | Negative | |
Sep2024 | ₹-50 Cr | Negative | |
Jun2024 | ₹-28 Cr | Negative | |
Mar2024 | ₹-27 Cr | Negative | |
Dec2023 | ₹-42 Cr | Negative | |
Sep2023 | ₹-13 Cr | Negative | |
Jun2023 | ₹-24 Cr | Negative | |
Mar2023 | ₹-28 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | -2429.69 % | Negative | |
Sep2024 | -1929.38 % | Negative | |
Jun2024 | -2787.28 % | Negative | |
Mar2024 | -1112.83 % | Negative | |
Dec2023 | -1704 % | Negative | |
Sep2023 | -414.38 % | Negative | |
Jun2023 | -634.42 % | Negative | |
Mar2023 | -1058.83 % | - |
SUVEN LIFE SCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹-1.79 | Negative | |
Sep2024 | ₹-2.28 | Negative | |
Jun2024 | ₹-1.29 | Negative | |
Mar2024 | ₹-1.22 | Negative | |
Dec2023 | ₹-1.92 | Negative | |
Sep2023 | ₹-0.58 | Negative | |
Jun2023 | ₹-1.1 | Negative | |
Mar2023 | ₹-1.27 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD